AF
MBII

Amalgamated Financial’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Amalgamated Financial’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$18K Buy
+16,485
New +$12.4K ﹤0.01% 2781

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's MBII Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Marrone Bio Innovations, Inc. (MBII) in Q1 2022: 16,485 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #2781 among its holdings.

71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Amalgamated Financial held 16,485 shares of Marrone Bio Innovations, Inc. worth $18K as of Q1 2022.
  • Marrone Bio Innovations, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Marrone Bio Innovations, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2781 holding.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.